Category: ACN Newswire

Yuzhou Group Holdings Company Limited (01628.HK) Announced the Official Effectiveness of Offshore Debt Restructuring, Marking a Key Step Toward Steady Development

HONG KONG, Sep 2, 2025 – (ACN Newswire via SeaPRwire.com) – On August 29, Yuzhou Group Holdings Company Limited (01628.HK) announced that its offshore debt management and restructuring efforts, which spanned over three years, have yielded decisive results. The offshore restructuring

More

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

TOKYO and CAMBRIDGE, Mass., Sept. 3, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai

More

Yuzhou Group Holdings Company Limited (01628.HK) Announced the Official Effectiveness of Offshore Debt Restructuring, Marking a Key Step Toward Steady Development

HONG KONG, Sep 2, 2025 – (ACN Newswire via SeaPRwire.com) – On August 29, Yuzhou Group Holdings Company Limited (01628.HK) announced that its offshore debt management and restructuring efforts, which spanned over three years, have yielded decisive results. The offshore restructuring

More